Applying Treatment Recommendations to the Management of Asthma

Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

Applying Treatment Recommendations to the Management of Asthma

 Faculty

Sandra Adams, MD
Professor of Medicine
UT Health San Antonio
Deputy Chief of Pulmonary Diseases and Critical Care Medicine
South Texas Veterans Health Care System
San Antonio, Texas

PROGRAM OVERVIEW

In this podcast episode we will review the treatment therapies for the management of moderate – to – severe Asthma. In addition, review important factors to use when deciding to use biological therapies and best practices in management.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Utilize current treatment recommendations and emerging clinical trial data to develop evidence-based treatment plans that reduce exacerbation risks and oral corticosteroid use.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of .33 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: .33 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded .33 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose. 

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
• Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
• Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures
2. Participate in the enduring activity
3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Release Date: October 7, 2022
Expiration Date: October 7, 2023